SCHEMBL10198975

SCHEMBL10198975

[C-]#[N+]c1cnc(Cl)nc1NC1CC(C)(C)NC(C)(C)C1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.37
ALDH1A1 P00352 3/20 0.35
MEN1 O00255 3/20 0.35
LMNA P02545 2/20 0.35
MAPT P10636 1/20 0.35
PKM P14618 1/20 0.35
ALOX15 P16050 1/20 0.35
ALOX12 P18054 1/20 0.35
RAD52 P43351 1/20 0.35
GFER P55789 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
TSHR P16473 1/20 0.34
AXL P30530 1/20 0.34
KCNH2 Q12809 2/20 0.33
JAK1 P23458 1/20 0.33
KDM4E B2RXH2 2/20 0.32
GAA P10253 1/20 0.32
POLB P06746 1/20 0.32
ADORA3 P0DMS8 1/20 0.31
ADORA1 P30542 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10198977 0.84 AXL (0.38) KMT2AAXLKCNH2
SCHEMBL429238 0.80 KMT2A (0.59) KMT2AALDH1A1MEN1LMNAMAPT
Hydrochloric Acid SCHEMBL431409 0.79 KMT2A (0.58) KMT2AALDH1A1MEN1LMNAMAPT
SCHEMBL429574 0.77 PRKCQ (0.41) KMT2AALDH1A1MEN1LMNAMAPT
SCHEMBL432301 0.75 SYK (0.44) ADORA3
SCHEMBL9069724 0.74 KMT2A (0.41) KMT2AALDH1A1MEN1LMNAMAPT
SCHEMBL13225991 0.73 KMT2A (0.54) KMT2AALDH1A1MEN1LMNAMAPT
SCHEMBL10444747 0.70 KMT2A (0.40) KMT2AALDH1A1MEN1LMNAMAPT
SCHEMBL23291669 0.69 ALDH1A1 (0.38) KMT2AALDH1A1MEN1LMNAMAPT
SCHEMBL23291733 0.69 ALDH1A1 (0.42) KMT2AALDH1A1MEN1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9732070-B2 Protein kinase C inhibitors and uses thereof RIGEL PHARMACEUTICALS, INC. (US) 2017-08-15 US disclosed
US-20170152246-A1 Protein Kinase C Inhibitors and Uses Thereof MIDCAP FINANCIAL TRUST 2017-06-01 US disclosed
US-9181222-B2 Protein kinase C inhibitors and uses thereof RIGEL PHARMACEUTICALS, INC. (US) 2015-11-10 US disclosed
US-20140329842-A1 Protein Kinase C Inhibitors and Uses Thereof RIGEL PHARMACEUTICALS, INC. (US) 2014-11-06 US disclosed
US-8710223-B2 Protein kinase C inhibitors and uses thereof RIGEL PHARMACEUTICALS, INC. (US) 2014-04-29 US disclosed
US-20120022092-A1 PROTEIN KINASE C INHIBITORS AND USES THEREOF MIDCAP FINANCIAL TRUST 2012-01-26 US disclosed
US-20110130415-A1 PROTEIN KINASE C INHIBITORS AND USES THEREOF RIGEL PHARMACEUTICALS, INC. 2011-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140329842-A1 Protein Kinase C Inhibitors and Uses Thereof PRKCH, PRKCA, PRKCB KMT2A 3505/4885ALDH1A1 4361/4885MEN1 3946/4885
US-20110130415-A1 PROTEIN KINASE C INHIBITORS AND USES THEREOF PRKCH, PRKCA, PRKCB KMT2A 3505/4885ALDH1A1 4361/4885MEN1 3946/4885
US-20120022092-A1 PROTEIN KINASE C INHIBITORS AND USES THEREOF PRKCH, PRKCA, PRKCB KMT2A 3505/4885ALDH1A1 4361/4885MEN1 3946/4885
US-20170152246-A1 Protein Kinase C Inhibitors and Uses Thereof PRKCH, PRKCA, PRKCB KMT2A 3505/4885ALDH1A1 4361/4885MEN1 3946/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.